Profile for Portola Pharmaceuticals Inc. (PTLA)

$ 18.03 H   0.00 (0.00%) Volume: 0 4:00 PM EDT 1-Jul-2020
Business Description:
Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.
Address: 270 E. Grand Avenue, South San Francisco, CA, USA, 94080
Telephone: +1 650 246-7000 Website:
Facsimile: +1 650 246-7376 Email: [email protected]
CEO: Scott Garland
Employees: 408 Market Cap: 1.42b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1269021
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)